These days, a wide range of health supplements is available across the market. But some of these complementary feedings do not offer promised benefits to consumers. Reportedly, two famous supplements touting promising effects on systemic inflammation may not live up to expectations. Usually, Omega-3 fatty acids are one of the most common forms of fish oil. Besides, decreasing systemic inflammation is all the go effort among the new-generation health-conscious people. Many diets and supplements are praised as a means to promote health and to chill this body inflammation. Besides, a relief in systemic inflammation is one of the many proclaimed advantages of vitamin D and fish oil supplements. In turn, they also claim to offer assistance in avoiding some chronic disorders.
On the other hand, systemic inflammation prepares the ground for a wide range of diseases, particularly for autoimmune conditions, like type-1 diabetes, cancer, etc. According to the latest study of Brigham and Women’s Hospital, not a single one in both offers assured effects. Indeed, some evidence has revealed that taking one of these supplements may surge systemic inflammation. The report published in AACC’s journal Clinical Chemistry is the first-ever study of its kind. Besides, the discovery might assist customers in making more informed choices about which supplements they should take.
The crucial study is a double-blind, randomly-assigned, and placebo-controlled trial. During the research, scientists have analyzed the impact of supplements of omega 3s (1gm/day), vitamin D (2000IU/day), or both. Karen Costenbader, MD, MPH, director of the Lupus Program in the Division of Rheumatology, Inflammation, and Immunity, is a co-author of the study. Costenbader and his team have tested levels of three popular biomarkers of inflammation at the beginning of the trial. After that, they have analyzed results after a year of taking additives or medication.
After one year, while tracing outcomes, the scientists had discovered that neither supplement lessened the biomarkers. Notably, the consumption of vitamin D supplements resulted in a rise of interleukin-6 (IL-6) by 8.2%, instead of decreasing it. The scientists have also found that among candidates who had lower fish consumption at the beginning of the trial, hsCRP levels did fall for those having the omega-3 fish oil supplement. In the end, Costenbander concluded that they had not seen a reduction in pointers of inflammation in the people who have had either supplement.